# A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

> **NCT04837222** · — · ACTIVE_NOT_RECRUITING · sponsor: **Takeda** · enrollment: 1000 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT04837222
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-07
- **Primary completion:** 2026-06-19
- **Final completion:** 2026-06-19
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837222, "A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04837222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*